Bioabsorbable Microfistula for Glaucoma Pressure Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for glaucoma, including medicinal and surgical methods, face challenges such as patient compliance issues, invasive procedures, and complications like infection and scarring, highlighting the need for a less invasive and effective solution for relieving intraocular pressure.

Innovation Solution

The development of an implantable microfistula channel made from cross-linked bioabsorbable material, such as gelatin, which is implanted through an ab interno approach via a hollow needle, providing a controlled drainage pathway between the anterior chamber and the sub-conjunctival space without requiring incision into the conjunctiva, and a system for precise implantation using a microprocessor-based controller.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical procedures such as trabeculectomy are used to treat glaucoma, then effective drainage of aqueous humor is achieved, but the procedure becomes very invasive causing irreversible changes, inflammation, scarring, and formation of filtering bleb

Engineering Contradiction:
Improveeffectiveness of glaucoma treatmentVSAvoidinvasiveness and complications
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The drainage system is segmented into multiple components: an intraocular portion positioned in the anterior chamber, an interfacial portion at the limbus, and an extraocular portion in the subconjunctival space. This segmentation allows each component to perform its specific function while minimizing overall invasiveness compared to traditional trabeculectomy

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The interfacial portion of the drainage device acts as an intermediary element that bridges the intraocular and extraocular portions. This intermediary structure facilitates controlled fluid transfer between the anterior chamber and subconjunctival space while reducing the need for extensive surgical intervention and minimizing tissue disruption

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If shunts such as Molteno, Barveldt, or Ahmed shunts are implanted, then drainage pathway is created, but chronic foreign body reactions and formation of chronic subconjunctival bleb occur

Engineering Contradiction:
Improvedrainage pathway creationVSAvoidchronic foreign body reactions
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The drainage device utilizes parameter changes in the form of expandable or collapsible structures that can change their configuration between implantation and operational phases. This allows the device to be inserted in a compact form and then expanded to create the drainage pathway, reducing the chronic foreign body presence and associated reactions

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The drainage system incorporates dynamic elements that can adjust their state based on physiological conditions. The ability of the device to expand, collapse, or adjust its configuration dynamically reduces the persistent foreign body effect and minimizes chronic inflammation and bleb formation

Inventive Principle:
Principle #15Dynamics

3Reliability

If medicinal treatments are used to treat glaucoma, then production of aqueous humor is reduced or flow is increased, but patient compliance becomes an issue requiring regular daily intervention

Engineering Contradiction:
Improvecontrol of aqueous humorVSAvoidpatient compliance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The drainage device provides self-service functionality by creating a passive drainage pathway that operates automatically based on pressure gradients without requiring patient intervention. The device regulates aqueous humor outflow continuously based on intraocular pressure conditions, eliminating the need for daily medication administration and improving compliance

Inventive Principle:
Principle #25Self-service

4Object-affected harmful factors

If less invasive surgical treatments are developed without incision into conjunctiva, then healing time is reduced and complications are minimized, but the complexity of precise implantation increases

Engineering Contradiction:
Improvehealing time and complicationsVSAvoidimplantation procedure complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The drainage device is pre-assembled with all components (intraocular portion, interfacial portion, extraocular portion) configured before implantation. This preliminary preparation allows for a simpler, less invasive implantation procedure where the pre-configured device is inserted through a minimally invasive approach, reducing surgical complexity while maintaining precise placement

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS9636254B2Systems for reducing pressure in an organ
Publication Date: 2017.05.02 AQUESYS INC
  • US9636254B2 patent drawing
  • US9636254B2 patent drawing
  • US9636254B2 patent drawing

AI summary

Methods, system and apparatus for relieving pressure in an organ such as, but not limited to, the eye are disclosed. The method includes implanting a bioabsorbable channel into the selected area of the organ using a delivery apparatus.